Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2018

Schedule of cash, cash equivalents, and restricted cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash as reported within the Unaudited Condensed Consolidated Balance Sheets to “Cash, cash equivalents, and restricted cash at end of period” as reported within the Unaudited Condensed Consolidated Statements of Cash Flows:



	Three Months Ended
	March 31,
In thousands	2018		2017
Cash and cash equivalents	$	85	$	1,747
Restricted cash included in Other assets	40,782		39,483
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	$	40,867	$	41,230

Schedule of earnings per share, basic and diluted reconciliation

The following table sets forth the reconciliations of net income and weighted average shares used for purposes of calculating the basic and diluted net income per common share for the periods indicated:



	Three Months Ended
	March 31,
In thousands	2018		2017
Numerator
Net income – basic	$	39,578	$	21,530
Effect of potentially dilutive securities
Interest on convertible senior notes	501		—
Net income – diluted	$	40,079	$	21,530

Denominator
Weighted average common shares outstanding – basic	392,742		389,397
Effect of potentially dilutive securities
Restricted stock and performance-based equity awards	5,169		3,600
Convertible senior notes	53,632		—
Weighted average common shares outstanding – diluted	451,543		392,997

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following securities could potentially dilute earnings per share in the future, but were excluded from the computation of diluted net income per share, as their effect would have been antidilutive:



	Three Months Ended
	March 31,
In thousands	2018	2017
Stock appreciation rights	2,954	5,044
Restricted stock and performance-based equity awards	431	1,229